trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim
COVID-19 vaccines grant cross-immunity to other coronaviruses
the verdict
CONTESTED
the evidence cuts both ways
confidence 32/100

While studies show that pre-existing seasonal coronavirus immunity can enhance vaccine responses and share peptide homology, other research finds limited back-boosting or robust cross-immunity, making the extent of true cross-protection contested.

The evidence we hold leans evenly split

How this was weighed

official record 3x · fact-check 2x · hedged 1x · crowd & reference 1x

  • HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reac · peer-reviewed · supports · weight 1.05 · 2021
  • Preexisting Humoral Immunity Against Seasonal Coronaviruses · peer-reviewed · supports · weight 1 · 2026
  • Evaluating Memory B Cell Cross-Reactivity Between Ancestral · peer-reviewed · refutes · weight 1 · 2026
  • Seroprevalence of endemic and emergent coronaviruses among S · peer-reviewed · refutes · weight 1 · 2026
Evidence for · 2
HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses
2021 · cited by 3
Paper 1 maps immunogenic peptides shared between SARS-CoV-2 and other human coronaviruses, indicating a potential for cross-reactive CD8+ T cell responses.
Evidence against · 2
Evaluating Memory B Cell Cross-Reactivity Between Ancestral and Future SARS-CoV-2 Variants-Evidence for Original Antigenic Sin.
2026 · cited by 0
Paper 4 highlights limitations in cross-reactivity and notes that boosting is constrained by antigenic imprinting.
See more details
More for · 1
Preexisting Humoral Immunity Against Seasonal Coronaviruses Enhances Antibody Responses on SARS-CoV-2 Vaccination.
2026 · cited by 0
Paper 9 reports that higher baseline immunity to seasonal betacoronaviruses enhances the antibody response to SARS-CoV-2 vaccination.
More against · 1
Seroprevalence of endemic and emergent coronaviruses among SARS-COV-2 patients and healthcare workers in Abidjan, Côte d'Ivoire.
2026 · cited by 0
Paper 10 finds no evidence of boosted antibody levels to endemic coronaviruses following SARS-CoV-2 infection, suggesting a lack of significant cross-reactive recall.
The paper trail · every fact has a biography
first checked01 Aug 2026
judged → CONTESTED · 3201 Aug 2026
This receipt carries no identity, shared or not. Sharing publishes your connection to it, not your data.
Check your own claim
Challenge the receipt
trust me, bro: win the argument, pass the class, survive peer review.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt